Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.70
- Piotroski Score 7.00
- Grade Buy
- Symbol (LH)
- Company Laboratory Corporation of America Holdings
- Price $239.15
- Changes Percentage (2.03%)
- Change $4.77
- Day Low $233.75
- Day High $240.37
- Year High $240.37
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
- Last Earnings 10/10/2024
- Ex-Dividend for 5/16 Dividend 11/26/2024
- Dividend Payable 12/13/2024
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $271.00
- High Stock Price Target $350.00
- Low Stock Price Target $240.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.68
- Trailing P/E Ratio 42.01
- Forward P/E Ratio 42.01
- P/E Growth 42.01
- Net Income $418.00 M
Income Statement
Quarterly
Annual
Latest News of LH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Celsius Holdings Inc (CELH) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
Celsius CEO, John Fieldly, discusses challenges in convenience store traffic but highlights the growth of sugar-free energy drinks. The partnership with Pepsi aims to drive category acceleration, incr...
By Yahoo! Finance | 22 hours ago -
Calhanoglu's controversial spot-kick earns Inter victory against Arsenal
Arsenal suffered a 1-0 defeat to Inter in the Champions League, with Calhanoglu scoring from a penalty. Despite a better second half, Arsenal couldn't find an equalizer. The loss adds to Arteta's moun...
By The Guardian | 1 day ago -
San Francisco Giants free-agent profile: Blake Snell, LHP
Blake Snell, a sought-after free-agent pitcher, may not return to the Giants due to various factors. Despite his exceptional performance, the Giants are unlikely to meet his contract demands....
By The New York Times | 1 day ago
